ODAIA PRESS RELEASE

ODAIA and Synergistix Team Up to Help Pharma Commercial Teams Optimize Engagement Through Predictive Analytics

Published on
March 1, 2023
3
min read
Return to Blog
|
This is some text inside of a div block.
min read

Heading

TORONTO – March 1, 2023 – Today we announced taking steps towards forming a business partnership that opens the door for future collaboration with Synergistix, a leading provider of sample accountability and CRM solutions for pharmaceutical manufacturers. The future collaboration will aim to equip pharma commercial teams with AI-powered predictive analytics to drive business growth through more direct, efficient and timely conversations with HCP customers through deployment of the Synergistix Customer Analysis and Targeting System (CATS) software suite.

“Synergistix’s industry-leading CRM platform combined in the future with ODAIA’s AI-driven insights can enable sales representatives to have more meaningful interactions with healthcare professionals (HCPs),” said Philip Poulidis, ODAIA CEO and co-founder. “We ingest multiple data sources into our AI models to deliver insights beyond what most pharma clients receive today, including physician-, territory- and national-level Rx forecasts and HCP-level channel preferences. These insights help pharma commercial teams personalize their messaging to HCPs, and improve their ability to achieve their business goals.” 

ODAIA leverages data from prescriptions, medical claims, population demographics and socioeconomics  to take the guesswork out of sales targeting and forecasting. A recent ODAIA study, which explored how AI helps pharma teams overcome today’s market challenges, found that over six months, ODAIA MAPTUAL helped sales reps save an average of 70 minutes a day on call preparation, increased HCP contacts by 32 percent, and ultimately increased new patient starts by six percent, resulting in a highly favorable return on investment (ROI). 

“Since our founding in 1997, we have always been focused on getting therapeutics to the patients that need them and now we can do it more efficiently,” said Don Schenker, Synergistix President and CEO. “With predictive analytics as accurate as ODAIA’s, pharma sales teams will have optimized segmentation that automatically updates an individual customer's segment when their behavior changes. This will ensure that communication is relevant for HCPs, which will help build their trust.”

This news comes ahead of the Synergistix conference March 1st – 3rd in Fort Lauderdale, Florida. The three-day event features sampling solutions, elements of effective life sciences CRM ecosystems, managing data transformation into information for successful sales teams, compliance and enhanced sampling programs. Attendees can also expect top-tier networking opportunities from peers and thought leaders alike.

About Synergistix

Since 1997, Synergistix has driven the commercial success of Life Sciences companies by enabling them to build strong customer relationships and highly effective sales teams. As the leading provider among CRM for Life Sciences companies, the company is valued for its collaborative approach, respected for our technical excellence and trusted to provide industry-leading security and innovation.

block-quote-author

About ODAIA

ODAIA is the leading AI company building the Customer Science Cloud for pharma. Innovative biopharmaceutical companies, including three of the top 15 global organizations, use ODAIA cloud solutions to enhance commercial engagement strategies by delivering predictive field intelligence as soon as your data refreshes.
We provide sales teams with ML-driven territory targeting, personalized call lists, GenAI-driven pre-call insights, and real-time territory assessments—directly within existing CRM workflows.
Contact
pr@odaia.ai
LinkedIn